GIUSTI, PIETRO
 Distribuzione geografica
Continente #
NA - Nord America 15.048
AS - Asia 4.057
EU - Europa 3.179
SA - Sud America 803
AF - Africa 712
OC - Oceania 90
Continente sconosciuto - Info sul continente non disponibili 35
Totale 23.924
Nazione #
US - Stati Uniti d'America 14.600
SG - Singapore 1.268
CN - Cina 945
HK - Hong Kong 713
IT - Italia 597
BR - Brasile 559
FI - Finlandia 377
DE - Germania 352
VN - Vietnam 288
UA - Ucraina 206
SE - Svezia 191
FR - Francia 186
PL - Polonia 173
RU - Federazione Russa 156
GB - Regno Unito 152
IE - Irlanda 130
TR - Turchia 97
IN - India 89
NL - Olanda 78
CA - Canada 47
MX - Messico 43
AR - Argentina 42
ES - Italia 41
JP - Giappone 36
AT - Austria 35
AZ - Azerbaigian 35
BE - Belgio 34
IQ - Iraq 33
SN - Senegal 32
ZA - Sudafrica 32
VE - Venezuela 31
GT - Guatemala 30
ID - Indonesia 30
JM - Giamaica 30
MD - Moldavia 29
PH - Filippine 29
AU - Australia 28
KE - Kenya 28
DO - Repubblica Dominicana 27
CI - Costa d'Avorio 26
CY - Cipro 26
LA - Repubblica Popolare Democratica del Laos 26
SK - Slovacchia (Repubblica Slovacca) 26
BO - Bolivia 25
CZ - Repubblica Ceca 25
EC - Ecuador 25
PA - Panama 25
PT - Portogallo 25
SA - Arabia Saudita 25
YT - Mayotte 25
LB - Libano 24
UZ - Uzbekistan 24
AL - Albania 23
AO - Angola 23
CO - Colombia 23
IR - Iran 23
KG - Kirghizistan 23
KR - Corea 23
MG - Madagascar 23
CG - Congo 22
CR - Costa Rica 22
KZ - Kazakistan 22
MK - Macedonia 22
NI - Nicaragua 22
PY - Paraguay 22
RO - Romania 22
TT - Trinidad e Tobago 22
BF - Burkina Faso 21
BZ - Belize 21
CM - Camerun 21
IS - Islanda 21
PE - Perù 21
TN - Tunisia 21
CH - Svizzera 20
EE - Estonia 20
GA - Gabon 20
HN - Honduras 20
MZ - Mozambico 20
NP - Nepal 20
PK - Pakistan 20
RS - Serbia 20
UY - Uruguay 20
BJ - Benin 19
BW - Botswana 19
BY - Bielorussia 19
CL - Cile 19
HU - Ungheria 19
NZ - Nuova Zelanda 19
SI - Slovenia 19
XK - ???statistics.table.value.countryCode.XK??? 19
CU - Cuba 18
MA - Marocco 18
AD - Andorra 17
AE - Emirati Arabi Uniti 17
DK - Danimarca 17
DZ - Algeria 17
EG - Egitto 17
KH - Cambogia 17
LU - Lussemburgo 17
ML - Mali 17
Totale 23.123
Città #
Fairfield 2.034
Woodbridge 1.619
Ann Arbor 1.211
Houston 1.171
Ashburn 1.103
Chandler 927
Jacksonville 819
Wilmington 769
Singapore 760
Seattle 733
Hong Kong 693
Cambridge 681
Boardman 345
Princeton 345
Dong Ket 226
Beijing 219
San Diego 202
Santa Clara 195
Medford 180
Des Moines 168
Padova 149
Nanjing 143
Bytom 136
Helsinki 115
Los Angeles 91
Munich 85
Guangzhou 73
Roxbury 58
New York 56
Shenyang 43
Hebei 42
Jiaxing 41
São Paulo 40
Dublin 37
London 37
Rome 37
Nanchang 36
Turku 36
Baku 34
Milan 33
Dakar 32
Washington 32
Jinan 30
Istanbul 28
Norwalk 28
Brooklyn 26
Buffalo 25
Hefei 24
Ho Chi Minh City 24
Panama City 24
Vientiane 24
Abidjan 23
Mestre 23
Warsaw 23
Antananarivo 22
Bishkek 21
Changsha 21
Chisinau 21
Nairobi 21
Luanda 20
Managua 20
Tashkent 20
Yenibosna 20
Kingston 19
Libreville 19
Mamoudzou 19
Nuremberg 19
Phoenix 19
Tianjin 19
Vienna 19
Chicago 18
Guatemala City 18
Havana 18
Montevideo 18
Tokyo 18
Andorra la Vella 17
Curitiba 17
Reykjavik 17
Tallinn 17
Amsterdam 16
Bamako 16
Cotonou 16
Dallas 16
Dushanbe 16
Harare 16
Johannesburg 16
Ouagadougou 16
Zhengzhou 16
Apia 15
Bridgetown 15
Brussels 15
Maputo 15
Nassau 15
Nouakchott 15
Noumea 15
San Francisco 15
Yerevan 15
Belo Horizonte 14
Borås 14
Brazzaville 14
Totale 16.886
Nome #
Overview of the pharmacological properties and therapeutic efficacy of phospholipid liposomes (Liposom Forte®) in patients with depressive disorders 307
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists. 305
Simultaneous measurement of phosphatidylglycerol and disaturated-phosphatidylcholine palmitate kinetics from alveolar surfactant. Study in infants with stable isotope tracer, coupled with isotope ratio mass spectrometry. 234
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway 226
Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator. 199
Co-ultramicronized palmitoylethanolamide/luteolin promotes the maturation of oligodendrocyte precursor cells 198
Mast cells, glia and neuroinflammation: partners in crime? 194
Ligand engagement of Toll-like receptors regulates their expression in cortical microglia and astrocytes 193
Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism 193
Curcumin Prevents Acute Neuroinflammation and Long-Term Memory Impairment Induced by Systemic Lipopolysaccharide in Mice 179
Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication? 176
Reference Values for a Panel of Cytokinergic and Regulatory Lymphocyte Subpopulations 169
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution 166
Co-Ultramicronized Palmitoylethanolamide/Luteolin-Induced Oligodendrocyte Precursor Cell Differentiation is Associated With Tyro3 Receptor Upregulation 161
Co-Ultramicronized Palmitoylethanolamide/Luteolin Facilitates the Development of Differentiating and Undifferentiated Rat Oligodendrocyte Progenitor Cells 159
Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons 157
A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis 155
Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis 153
Intracellular glutathione levels determine cerebellar granule neuron sensitivity to excitotoxic injury by kainic acid 152
A proteomic approach in the study of an animal model of Parkinson's disease 151
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron 151
Systematic review of pharmacological properties of the oligodendrocyte lineage 149
The Difficulty of Diabetic Therapy: an Observational Retrospective Study from Actual Clinical Practice 149
Bisdemethoxycurcumin and Its Cyclized Pyrazole Analogue Differentially Disrupt Lipopolysaccharide Signalling in Human Monocyte-Derived Macrophages 148
Current and emerging avenues for Alzheimer's disease drug targets 146
Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives 141
A new place conditioning paradigm to study tolerance to opiates in mice. 141
Synaptic Plasticity, Dementia and Alzheimer Disease 141
A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment 138
Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors 138
Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. 137
Neuroepigenetics and Alzheimer's Disease: An Update 137
Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: A 5-year literature update and critical review 137
Toll-Like Receptors 2, -3 and -4 Prime Microglia but not Astrocytes Across Central Nervous System Regions for ATP-Dependent Interleukin-1β Release 136
Activated carbon as an external antidote: bringing it up to date 136
Consumption of opioid analgesics in Italy: light at the end of the tunnel? 135
Fluoxetine-induced proliferation and differentiation of neural progenitor cells isolated from rat postnatal cerebellum 135
Acetylcholinesterase inhibition by tacrine analogues 134
Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. 134
Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian Region 134
INFLUENCE OF GLYCINE ON MORPHINE-INDUCED ANTINOCICEPTION IN MICE 133
A 6-hydroxydopamine in vivo model of Parkinson's disease. 132
Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia 132
Serum amyloid A primes microglia for ATP-dependent interleukin-1β release 131
Acetylcholinesterase Inhibitors: Synthesis and Structure-Activity Relationships of omega-[N-Methyl-N-(3-alkylcarbamoyloxyphenyl)-methyl]aminoalkoxyheteroaryl Derivatives. 130
The P2X7 purinergic receptor: from physiology to neurological disorders 130
A sample research of hospitalized acute intoxication cases using an epidemiological form. 130
Active induction of experimental autoimmune encephalomyelitis in C57BL/6 mice 130
A model of systemic inflammation to study neuroinflammation 129
Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain. 128
Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues. 127
Effect of acute and chronic tramadol on [3H]-norepinephrine-uptake in rat cortical synaptosomes. 126
Cyclovinylogues of guanethidine. 126
Basic derivatives of 5-benzoyl-10,11-dihydro-5H-dibenz[b,f]azepine. 126
Glycine antinociceptive effects in mice 126
Impairment of optokinetic nystagmus and optokinetic after-nystagmus in animals treated with 3-acetylpyridine 126
Some cases of acute intoxications from compulsive use of isoaminile 125
Analgesic properties of N-terminal substituted phenylalanyl-alanine. 123
Conditioned place preference: no tolerance to the rewarding properties of morphine. 123
Antidepressant drug prescribing patterns to outpatients of an italian local health authority during the years 1998 to 2008. 123
Further evidences for neuroprotective effects of melatonin. 122
Microglia and mast cells: two tracks on the road to neuroinflammation. 120
Opioids in Italy: is marketing more powerful than the law? 119
Development of small-diameter vascular prostheses which release bioactive agents. 119
Abecarnil enhances recovery from diazepam tolerance. 119
Resource consumption and costs of treating pain in patients affected by cancer in a district of northeast Italy. 118
Astrocyte-Microglia Cooperation in the Expression of a Pro-Inflammatory Phenotype. 118
Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review. 117
Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice 116
ANTINOCICEPTIVE ACTION OF GLYCINAMIDE 115
Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal in mice. 114
Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity 114
Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate in rats. 113
Molecular network-selected pharmacogenomics in a case of bipolar spectrum disorder 113
Isoniazid-induced inhibition of GABAergic transmission enhances the efficacy of imidazenil, a new partial agonist of benzodiazepine receptors 112
The first application of Mössbauer spectroscopy in pharmacokinetics. I. Iron distribution in the rat 112
Neuroprotective action of the pineal hormone melatonin against excitotoxicity. Receptor abuse-dependent antagonism (RADA). 111
Expression and Differential Responsiveness of Central Nervous System Glial Cell Populations to the Acute Phase Protein Serum Amyloid A 111
SSRI treatment induces a neurogenic response in rat cerebellar granule cells 110
Proteomic study of 6-OHDA-induced neurodegeneration of rat nigrostriatal pathway 110
Cerebellar granular cell cultures as an in vitro model for antidepressant drug-induced neurogenesis 109
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 109
Antinociceptive effect of some carboxypeptidase A inhibitors in comparison with D-phenylalanine. 108
Real-practice thromboprophylaxis in atrial fibrillation 108
Synthetic enkephalins. Addicting properties and conformational studies in solution. 107
Neuroendocrine effects of a cycle of fangotherapy 107
Benefit of statins in daily practice? A six-year retrospective observational study 106
Transgenic Mouse Models of Parkinson's Disease and Huntington's Disease 105
Kainic acid induces selective mitochondrial oxidative phosphorylation enzyme dysfunction in cerebellar granule neurons: protective effects of melatonin and GSH ethyl ester 105
Effects of the neurotoxin MPTP and pargyline protection on extracellular energy metabolites and dopamine levels in the striatum of freely moving rats. 105
Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl -D-Aspartate excitotoxicity 104
Sodium-activated potassium current in mouse diaphragm. 103
Cost-of-illness della patologia diabetica in Italia: focus sul paziente con diabete di tipo 2 103
The Effect of C-Phycocyanin on Microglia Activation Is Mediated by Toll-like Receptor 4 103
On the effect of some purinergic agents at the mouse end-plate 102
Gas-liquid chromatographic determination of dextromethorphan in serum and brain. 102
'Non-narcotic' analgesia in the mouse by transcutaneous electrical stimulation 102
Melatonin prevents the delayed death of hippocampal neurons induced by enhanced excitatory neurotransmission and the nitridergic pathway. 101
SSRI treatment induces a neurogenic response in rat cerebellar granule cells 101
An experimental study on dependence liability of zipeprol. 101
Totale 13.574
Categoria #
all - tutte 77.303
article - articoli 65.563
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 1.658
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.911
Totale 147.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.977 0 0 66 222 81 193 70 204 344 183 285 329
2021/20222.696 60 427 315 185 93 85 125 317 131 42 355 561
2022/20232.093 457 194 26 215 372 292 4 116 249 33 87 48
2023/20241.203 50 119 178 102 71 185 43 78 46 72 123 136
2024/20254.157 31 148 178 194 603 171 237 254 397 143 726 1.075
2025/20263.495 545 1.437 1.513 0 0 0 0 0 0 0 0 0
Totale 24.017